Glutathione S-transferases polymorphisms confer susceptibility to senile cortical cataract in the Han Chinese population by Jiang, Zhengxuan et al.
Glutathione S-transferases polymorphisms confer susceptibility to
senile cortical cataract in the Han Chinese population
Zhengxuan Jiang, Kun Liang, Qing Zhang, Liming Tao
Department of Ophthalmology, the Second Affiliated Hospital of Anhui Medical University, Hefei, P.R. China
Purpose: The aim of this study was to examine whether glutathione S-transferase (GST) polymorphisms were associated
with a susceptibility to age-related cortical cataract (cortical ARC) in the Han Chinese population.
Methods: Glutathione S-transferase M1 (GSTM1) and glutathione S-transferase T1 (GSTT1) gene polymorphisms were
genotyped in 422 Han Chinese patients with age-related cortical cataract, and in 312 age, sex, and ethnically matched
healthy controls, using a multiplex polymerase chain reaction.
Results: The results showed that the GSTM1 positive genotype had an increased risk of developing cortical ARC
(p=0.0002, odds ratio [OR] 1.74, 95% CI 1.30 to 2.34). There was a statistically significant association between the
GSTM1 positive genotype and the risk of cataract development in both female and male groups (p=0.026, OR 1.58, 95%
CI 1.05 to 2.36; p=0. 002, OR 1.97, 95% CI 1.27 to 3.04, respectively). A combination of GSTM1 positive and GSTT1
null genotypes was associated with the risk of developing age-related cortical cataract (p=0.002, OR 2.19, 95% CI 1.33
to 3.60). The results revealed that the GSTM1 positive genotype was significantly higher in the smoker patients group as
compared to the non-smoker patients group (p=0. 016, OR 1.62, 95% CI 1.09 to 2.39). Logistic regression analysis revealed
that smoking may be a risk factor for the development of ARC (r=0.120, p=0.013).
Conclusions: Our study suggests that the GSTM1 positive genotype and a combination of GSTM1 positive and GSTT1
null genotypes may be associated with a susceptibility to age-related cortical cataract in the Han Chinese population. The
current study indicates that smoking may be an important factor in the development of cortical ARC.
Cataract is one of the leading causes of visual impairment
and blindness in the world today [1]. It is estimated that
cataract affects approximately 37 million people and accounts
for  48%  of  blindness  worldwide  [2].  Age-related  cataract
(ARC) accounts for about 80% of all cataracts [1]. ARC is
classified  as  nuclear,  cortical,  or  posterior  sub-capsular
cataract, according to the location of the opacity within the
lens  [3].  Although  the  pathogenesis  of  ARC  is  not  fully
understood, many studies suggest that genetic factors and
oxidative stress are two major factors in the development of
age-related  cataract  [4].  Family-based  linkage  studies
reported multiple ARC loci at 1q31, 2p24, 2q11, 4q28, 15q13,
and 6p12-q12 [5]. Moreover, it is known that among the four
types  of  ARC,  cortical  cataract  is  highly  heritable  [6,7].
Previous studies have identified several genes to be associated
with ARC, such as heat shock protein (HSF4), gap junction
protein alpha 8 (GJA8), eph-receptor tyrosinekinase-type A2
(EPHA2),  and  glutathione  S-transferase  (GST).  However,
these  genes  account  only  partially  for  the  genetic
predisposition to ARC. Studies need to be performed to search
for other genes, related to oxidative stress, which may be
responsible for the development of ARC.
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Glutathione S-transferases (GSTs) are a group of dimeric
detoxification  enzymes  that  play  an  important  role  in
detoxifying  exogenous  and  endogenous  toxic  compounds
under  conditions  of  oxidative  stress  [8-11].  The  GST
isoenzymes exist in human tissue, and human lens tissue has
been  reported  to  express  class  mu,  theta,  and  pi  [12].
Glutathione S-transferase M1 (GSTM1) and glutathione S-
transferase T1 (GSTT1) have been found to have functional
polymorphisms and have been studied extensively in relation
to disease [11,13-15]. As the genetic factor is a major cause
of  cortical  ARC,  cortical  ARC  patients  were  selected  as
subjects for this study. The study was designed to examine
whether there is an association of GST polymorphisms with
susceptibility to cortical ARC in the Han Chinese population.
METHODS
Patients  and  healthy  controls:  A  total  of  422  age-related
cortical cataract patients and 312 age, sex, and ethnically
matched healthy controls were recruited from The Second
Affiliated Hospital of Anhui Medical University (Anhui, P.R.
China). All the patients and healthy controls underwent a full
ophthalmic examination, including visual acuity, slit lamp
examination  of  the  anterior  chamber,  gonioscopy,  central
corneal  thickness,  measurement  of  intraocular  pressure,
fundus examination with special attention paid to optic disc
parameters, and visual field. The degree of cataract in all
patient eyes was either CII or CIII, according to the Lens
Opacities Classification System, version II (LOCS II) [16].
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1247Subjects were selected who were free of other ocular disease
or systemic diseases. Information on hypertension, diabetes
mellitus, prolonged corticosteroid administration, and other
known causes of cataract was excluded from this study. All
subjects were interviewed to get data on their smoking habits.
The  study  was  approved  by  the  local  institutional  ethics
committee  of  The  Second  Affiliated  Hospital  of  Anhui
Medical University. All procedures followed the tenets of the
Declaration  of  Helsinki.  Written,  informed  consent  was
obtained  from  all  the  subjects.  After  obtaining  written,
informed consent, we took 5 ml of peripheral blood from each
participant. Blood samples were collected in EDTA tubes and
kept at −70 °C until use. Genomic DNA was extracted from
peripheral  blood  by  the  QIAamp  DNA  Blood  Mini  Kit
(Qiagen, Hilden, Germany).
Genotyping: The GSTM1 and GSTT1 polymorphisms were
genotyped  using  the  multiplex  polymerase  chain  reaction
(PCR).  The  PCR  primers  used  in  present  study  were  as
described [17]. Primers for GSTM1 were 5′-GAA CTC CCT
GAA AAG CTA AAG C-3′ and 5′-GTT GGG CTC AAA
TAT ACG GTG G-3′. Primers for GSTT1 were 5′-TTC CTT
ACT GGT CCT CAC ATC TC-3′ and 5′-TCA CCG GAT
CAT GGC CAG CA-3′. To avoid false- negative results, the
β-globin gene was used as an internal control. Primers for β-
globin were 5′-CAA CTT CAT CCA CGT TCA CC-3′ and
5′-GAA  GAG  CCA  AGG  ACA  GGT  AC-3′.  Each  PCR
reaction was performed in a 10-μl reaction mixture containing
5 μl Premix Taq (Ex Taq Version; TaKaRa Biotechnology Co.
Ltd., Dalian, China), 15 pmol primers, and 0.1 μg of genomic
DNA for ampliﬁcation of the DNA. The conditions of PCR
were  as  follows:  Amplification  was  performed  by  initial
denaturation at 94 °C for 5 min, followed by 33 cycles at 94 °C
for 40 s, at 64 °C for 40 s, and at 72 °C for 40 s, with a final
extension at 72 °C for 5 min.
Digestion products were visualized on a 2.0% agarose
gel, and were stained with GoldView (SBS Genetech, Beijing,
China). The product lengths for GSTM1, GSTT1, and β-globin
were 219 bp, 459 bp, and 268 bp, respectively. In the presence
of the β-globin band condition, an absence of PCR product for
GSTM1 or GSTT1 was described as GSTM1 null or GSTT1
null genotype.
Statistical analysis: Student’s t-test was used to compare the
ages  of  the  patient  and  control  groups.  The  GSTM1  and
GSTT1  genotypes  were  compared  between  patients  and
controls by the χ2 test, using SPSS (version 10.0; SPSS Inc.,
Chicago,  IL).  Logistic  regression  analysis  was  used  to
estimate  the  actual  risk  conferred  by  the  genetic  variants
(version 10.0; SPSS Inc.). The p-values were corrected (Pc)
with the Bonferroni correction by multiple comparison with
the number of analyses performed. Statistical significance was
set at a p value <0.05.
RESULTS
Four  hundred  and  twenty-two  patients  with  age-related
cortical  cataracts  and  three  hundred  and  twelve  healthy
controls were recruited for the present study. The average age
TABLE 1. FREQUENCIES OF GENOTYPES OF GST POLYMORPHISMS IN ARC PATIENTS AND CONTROLS.
Genotype Sex Patients with ARC Controls PC OR (95% CI)
GSTM1 Both sex
Positive   246 (58.3%) 139 (44.6%) 0.0002 1.74 (1.30–2.34)
Null   176 (41.7%) 173 (55.4%)
GSTT1
Positive   201 (47.6%) 174 (55.8%) 0.186 1.22 (0.91–1.63)
Null   221 (52.4%) 138 (44.2%)
GSTM1 Male
Positive   122 (62.8%) 68 (46.3%) 0.002 1.97 (1.27–3.04)
Null   72 (37.2%) 79 (53.7%)
GSTT1
Positive   95 (48.9%) 83 (56.4%) 0.170 0.74 (0.48–1.14)
Null   99 (51.1%) 64 (43.6%)
GSTM1 Female
Positive   124 (54.4%) 71 (43.1%) 0.026 1.58 (1.05–2.36)
Null   104 (45.6%) 94 (56.9%)
GSTT1
Positive   106 (46.5%) 91 (55.1%) 0.090 0.71 (0.47–1.06)
Null   122 (53.5%) 74 (44.9%)
GST, glutathione S-transferase; OR, odds ratio; Pc, Bonferroni corrected p value.
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1248of  the  cortical  ARC  patients  was  59.61±9.52  years.  The
average age of the healthy controls was 57.34±10.27 years.
There  was  no  significant  difference  between  patients  and
controls as regards age.
Distribution  of  the  GSTM1  and  GSTT1  genotypes  in
patients and healthy controls are shown in Table 1. The results
show that the frequency of the GSTM1 positive genotype is
significantly  higher  in  the  patients  relative  to  the  healthy
controls. The frequency of the GSTT1 null/positive genotype
was not significantly different between the patients and the
healthy controls. We also investigated the association between
a  combination  of  GST  genotypes  and  cortical  ARC.  The
results are shown in Table 2. It was found that the risk of
cortical ARC was significantly increased in patients with a
combination of GSTM1 positive and GSTT1 null genotypes.
We questioned whether the sex of the subjects can affect
the GST genotype, so tested the association between GST
genotype and cataract risk, stratified by sex. There was a
statistically  significant  association  between  the  GSTM1
positive genotype and ARC in both female and male groups.
The result revealed that in this study gender was not a risk
factor for the development of ARC.
To search for risk factors in the development of ARC, we
divided the patients’ samples into two groups according to
smoking status. The results showed that the GSTM1 positive
genotype was significantly higher in the smoker patients’
group.  The  results  were  shown  in  the  Table  3.  Age  and
smoking status had reported to involve in the pathogenesis of
ARC, Logistic regression analysis was used to estimate the
actual  risk  conferred  by  the  genetic  variants.  The  result
TABLE 2. ASSOCIATION BETWEEN CORTICAL CATARACT AND COMBINATION OF GSTM1 AND GSTT1 GENOTYPES.
GSTM1 GSTT1 Patients with ARC
(%)
Controls (%) PC OR (95% CI)
Positive Positive 109 (25.8%) 81 (26.0%) 0.008 1.76 (1.15–2.67)
Positive Null 137 (32.5%) 58 (18.6%)
Null Positive 92 (21.8%) 93 (29.8%)    
Null Null 84 (19.9%) 70 (22.4%)    
GST, glutathione S-transferase; OR, odds ratio; Pc, Bonferroni corrected p value.
TABLE 3. ASSOCIATION BETWEEN SMOKING STATUS AND GST POLYMORPHISMS IN THE CORTICAL CATARACT GROUP.
Genotype Smoker group (%) Nonsmoker group
(%)
PC OR (95% CI)
GSTM1
Positive 139 107 0.016 1.62 (1.09–2.39)
Null 78 97
GSTT1
Positive 102 99 0.791 0.95 (0.65–1.39)
Null 115 106
GST, glutathione S-transferase; OR, odds ratio; Pc, Bonferroni corrected p value.
TABLE 4. LOGISTIC REGRESSION ANALYSIS BETWEEN AGE, SMOKING STATUS AND GST POLYMORPHISMS IN THE CORTICAL
CATARACT GROUP.
Factor Wald r p-value OR (95% CI)
GSTM1
Smoking 6.09 0.120 0.013 1.63 (1.10–2.41)
Age 0.00 0.001 0.983 1.00 (0.97–1.04)
GSTT1
Smoking 1.58 0.043 0.787 0.96 (0.66–1.40)
Age 0.02 0.003 0.947 1.04 (0.93–1.12)
OR, odds ratio.
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development of ARC (r=0.120, p=0.013). Table 4 shows these
results.
DISCUSSION
Age-related cataract is one of the most common causes of
useful vision loss in the world [18]. Although the etiology and
pathogenesis of ARC are still unclear, several hypotheses
have been proposed, including an oxidative stress lesion and
a genetic factor. Among the assumptions, the oxidative stress
lesion mechanism has been considered the major cause of
senile  cataract.  Thus,  the  lens  must  have  an  efficient
detoxification system to protect it against the toxic effects of
oxidative damage [8,10,19]. Recent biochemical studies have
suggested that GSTs are important enzymes in defense against
oxidative stress. However, they also play roles in reactions
that  result  in  toxic  products  which  may  cause  structural
alterations to the proteins [20]. As genetic polymorphisms
may alter the function of these enzymes, many studies have
attempted to show an association between GST polymorphic
variants and disease susceptibility. The GSTM1 and GSTT1
polymorphisms were reported to be associated with many
diseases, including glaucoma [21,22], acute leukemia [23],
senile macular degeneration [24], and cataract, in the different
populations tested [25]. These results stimulated us to test
whether  the  polymorphisms  of  GSTM1  and  GSTT1  could
contribute to the development of cortical ARC in the Han
Chinese population.
The  present  study  suggests  that  the  GSTM1  positive
genotype is associated with cortical ARC and may be a genetic
risk factor for the development of this disease. These results
agree  with  previous  findings  reporting  on  senile  cortical
cataract  in  the  Estonian  and  Turkish  populations  [20,26].
However, the GSTM1 null genotype has been reported to be
associated  with  an  increased  risk  of  cataract  in  Asian
populations [15,25]. The result showed that the GSTT1 null
genotype was not associated with cortical ARC. Similarly, no
association was found between the GSTT1 null genotype and
cataract in Iranian [27], Turkish and Estonian populations
[26,28]. In contrast, the GSTT1 null genotype was reported to
be associated with an increased risk for senile cataract in Asian
populations, and with primary open-angle glaucoma (POAG)
in a Turkish population [11,15]. The association between the
genotype profile and cortical ARC was also tested. The results
showed that a combination of GSTM1 positive and GSTT1 null
genotypes  was  significantly  associated  with  cortical  ARC
development. Similarly, a combination of GSTM1 positive
and GSTT1 null genotypes was associated with the incidence
of POAG in a Turkish population [11]. Many factors might
explain the difference in results: First, the differences in the
number of subjects in genetics studies may result in different
outcomes [15]. Second, the patients in the other study included
all types of senile cataracts, while our study involved only
cortical  cataracts.  Furthermore,  differences  in  the  ethnic,
genetic and environmental background of the subjects may
have influenced the results. Subjects in our study all came
from the Anhui province, which is in the central part of China,
while the subjects of the other study were recruited from
Beijing city, which is in the northern part of China [25].
There are several reasons to account for the association
between the GSTM1 positive genotype and cortical ARC. On
the one hand, GST enzymes are very useful for detoxification
and defense against oxidative stress, but they are also involved
in reactions that result in toxic products. The toxic products
may lead to structural damage of the proteins in the lens that
then cause lens opacification [20,26]. On the other hand, the
GST activity is significantly decreased in cataractous lens
compared  with  that  in  normal  lens,  the  GSTM1  positive
genotype may have lost its ability to detoxify the harmful
substances under oxidative stress.
There  are  many  clinical  and  life-style  factors  may
influence the results of association study. In current study, the
patients were divided into two groups according to smoking
status. The GSTM1 positive genotype was significantly higher
in the smoker patients group. It may be assumed that smoking
leads to an increase of toxic compounds in the lens tissue. The
increased toxicity would then lead to damage of the lens
protein [19,26]. As age and smoking may both be factors in
the pathogenesis of ARC, logistic regression analysis was
used  to  estimate  the  actual  risk  conferred  by  the  genetic
variants. The results suggest that smoking may be a risk factor
in the development of ARC and may provide very useful
information for preventing the ARC. Although some studies
reported  that  the  effect  of  gender  differences  on  the
association between GST polymorphisms and senile cataract,
this study did not find any association between them. It was
consistent  with  the  result  of  Meta-analysis  between  GST
polymorphisms and senile cortical cataract [15].
As with other candidate gene studies, there are several
limitations  inherent  to  our  study.  First,  the  subjects  were
recruited from a Han Chinese population only. The results
need to be confirmed in other ethnic populations. Second,
extensive research is needed to clarify how the GST genotypes
influence  susceptibility  to  cataract.  Third,  many  recent
publications  have  analyzed  the  single  copy  deletions  in
GSTM1  and  GSTT1,  but  this  study  has  only  tested  the
complete deletions in them, and not the single copy deletions.
In  addition,  the  patients  in  this  study  were  only  cortical
cataract  cases,  other  types  of  ARC  should  be  tested  in
subsequent studies.
In summary, our study showed that the GSTM1 positive
genotype and a combination of GSTM1 positive and GSTT1
null genotypes were associated with susceptibility to cortical
ARC.  The  predisposing  effect  of  the  GSTM1  positive
genotype to cortical ARC was stronger in the smoker patients
group, and smoking may therefore be a risk factor for this
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1250disease. This study may give some information for diagnosis
and preventing the ARC.
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